FDA Pushes For Greater Clinical Trial Patient Diversity
U.S. Food and Drug Administration Commissioner Margaret A. Hamburg said on Tuesday that the agency will launch an action plan promoting greater diversity in clinical trial patient populations this summer, claiming...To view the full article, register now.
Already a subscriber? Click here to view full article